Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iradimed (IRMD) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $463976.0.

  • Iradimed's Non Operating Income fell 2625.95% to $463976.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 992.08%. This contributed to the annual value of $2.3 million for FY2024, which is 3570.21% up from last year.
  • According to the latest figures from Q3 2025, Iradimed's Non Operating Income is $463976.0, which was down 2625.95% from $539247.0 recorded in Q2 2025.
  • In the past 5 years, Iradimed's Non Operating Income registered a high of $642217.0 during Q2 2024, and its lowest value of -$14915.0 during Q1 2022.
  • Moreover, its 5-year median value for Non Operating Income was $449733.0 (2022), whereas its average is $321180.7.
  • Within the past 5 years, the most significant YoY rise in Iradimed's Non Operating Income was 1134358.78% (2022), while the steepest drop was 16337.63% (2022).
  • Quarter analysis of 5 years shows Iradimed's Non Operating Income stood at $3930.0 in 2021, then surged by 11343.59% to $449733.0 in 2022, then increased by 16.03% to $521810.0 in 2023, then increased by 4.28% to $544160.0 in 2024, then dropped by 14.74% to $463976.0 in 2025.
  • Its Non Operating Income was $463976.0 in Q3 2025, compared to $539247.0 in Q2 2025 and $513973.0 in Q1 2025.